| Old Articles: <Older 32111-32120 Newer> |
|---|
 |
The Motley Fool
September 12, 2008
Christopher Barker |
In Defense of Gold The luster of gold is no fleeting flash, according to those bullish on the yellow metal.   |
The Motley Fool
September 12, 2008
Morgan Housel |
Is JPMorgan Back at WaMu's Doorstep? Rumor has it that JPMorgan Chase is back in talks to buy Seattle-based Washington Mutual, five months after it made its first offer. |
The Motley Fool
September 12, 2008
Brian Lawler |
A New Wrinkle for an Old Drug Allergan's muscle relaxant Botox performs well in two studies testing its ability to prevent migraine headaches. |
The Motley Fool
September 12, 2008
Alex Dumortier |
Who Will Buy Lehman? The investment bank's days of independence are numbered. |
The Motley Fool
September 12, 2008
Morgan Housel |
Thursday's Wild Financial Stocks If you own financial stocks, then you know that yesterday was one of the wildest days for them in quite a while. |
The Motley Fool
September 12, 2008
Morgan Housel |
Another Blow for WaMu After releasing a mid-quarter update on the health of its books, the besieged bank had its credit downgraded by Moody's. |
The Motley Fool
September 12, 2008
Tim Beyers |
TASER's Deadliest Weapon After a stinging legal defeat in June, TASER International prevails in two cases this week. |
The Motley Fool
September 12, 2008
Brian Lawler |
King's Unstoppable Urge to Merge King Pharmaceuticals announces it has increased its offer to acquire Alpharma, and it is now taking that bid directly to the shareholders. |
The Motley Fool
September 12, 2008
Colleen Paulson |
3 Stocks to Consume Now Shop, eat, and drink your way to investment success. Take a look at: Borders... Diageo... Rocky Mountain Chocolate Company... |
The Motley Fool
September 12, 2008
Alex Dumortier |
Lehman's Worst Gamble Ever Lehman's CEO may have overplayed a weak hand for far too long, giving any current suitor a better buying opportunity. |
| <Older 32111-32120 Newer> Return to current articles. |
